MAXIMORE PHARMA FUTURE LLP
LLPIN: ACK-3330 Active
Full company report
Balance sheet and P&L, charges, auditors, resolutions, funding, MSME dues and complaints, checked by our team.
₹999 + GST · delivered in 3 working days
Get full reportAlready bought it? View it in your account
Company information
MAXIMORE PHARMA FUTURE LLP (ACK-3330) is a limited liability partnership incorporated on 13 Nov 2024. It is classified as a non-government company (company limited by shares) and is registered with the ROC Hyderabad. Its authorised share capital is ₹5,00,000 and its paid-up capital is ₹5,00,000. It is engaged in trading.
Its designated partners are Naresh Goda, Sreedhar Kakumanu, Dasari Anil Prabhu Kumar and Hima Sai Sandeep Dasari. Its registered office is at D.No.2-29/AG, PLOT No.5 TO 11, FLAT No.311, APARNA GREENHOMES,BESIDE STAR HOSPITAL, NANAKRAMGUDA, HYDERABAD,Seri Lingampally,K.V.Rangareddy,Telangana,India-500032, and it can be reached at maximorefuturellp@gmail.com.
The current status of MAXIMORE PHARMA FUTURE LLP is Active.
Basic information
- LLPIN
- ACK-3330
- Name
- MAXIMORE PHARMA FUTURE LLP
- Company status
- Active
- ROC
- ROC Hyderabad
- Company category
- Company limited by shares
- Company sub-category
- Non-government company
- Class of company
- Private
- Date of incorporation
- 13 Nov 2024
- Age of company
- 1 year, 11 months, 26 days
- Activity
- Trading
Annual compliance status
- Date of last annual general meeting
- Not available yet
- Date of latest balance sheet
- Not available yet
Key numbers
- Authorised share capital
- ₹5,00,000
- Paid-up share capital
- ₹5,00,000
- Total assets
- Included in the full report
- Revenue
- Included in the full report
- Profit after tax
- Included in the full report
- Employee benefit expenses
- Included in the full report
Designated partners of MAXIMORE PHARMA FUTURE LLP
As per records filed with the Ministry of Corporate Affairs.
Current designated partners
| DIN | Name | Designation | Appointed on |
|---|---|---|---|
| 09382574 | Naresh Goda | Designated Partner | – |
| 08923149 | Sreedhar Kakumanu | Designated Partner | – |
| 07568717 | Dasari Anil Prabhu Kumar | Designated Partner | – |
| 10306144 | Hima Sai Sandeep Dasari | Designated Partner | – |
Other directorships of Naresh Goda
| Company | CIN | Designation | Appointed on | Ceased on |
|---|---|---|---|---|
| MAXIMORE TECHNOLOGIES PRIVATE LIMITED | U72900TG2022PTC167218 | Director | – | Ongoing |
Other directorships of Sreedhar Kakumanu
| Company | CIN | Designation | Appointed on | Ceased on |
|---|---|---|---|---|
| MAXIMORE BUILDERS PRIVATE LIMITED | U45400TG2022PTC167229 | Director | – | Ongoing |
Other directorships of Dasari Anil Prabhu Kumar
| Company | CIN | Designation | Appointed on | Ceased on |
|---|---|---|---|---|
| EDUBLOOM VENTURES LLP | ACW-5532 | Designated Partner | – | Ongoing |
| ADORNED INFRA PRIVATE LIMITED | U70109TG2022PTC161879 | Director | – | Ongoing |
Contact details of MAXIMORE PHARMA FUTURE LLP
- Registered office
- D.No.2-29/AG, PLOT No.5 TO 11, FLAT No.311, APARNA GREENHOMES,BESIDE STAR HOSPITAL, NANAKRAMGUDA, HYDERABAD,Seri Lingampally,K.V.Rangareddy,Telangana,India-500032
- City, state and PIN
- Seri Lingampally, Telangana – 500032
See the full picture of MAXIMORE PHARMA FUTURE LLP
The sections below are filled in your report from official MCA filings: financial statements, charges, auditors, resolutions, funding, MSME dues and complaints.
Balance sheet of MAXIMORE PHARMA FUTURE LLP
In full report
Assets, liabilities and equity as filed in the annual financial statements (AOC-4), for up to the last 5 financial years.
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Equity And Liabilities | ||
| Share capital | ||
| Reserves and surplus | ||
| Long-term borrowings | ||
| Other long-term liabilities | ||
| Long-term provisions | ||
| Short-term borrowings | ||
| Trade payables | ||
| Other current liabilities | ||
| Short-term provisions | ||
| Total equity and liabilities | ||
| Assets | ||
| Property, plant and equipment | ||
| Intangible assets | ||
| Capital work in progress | ||
| Non-current investments | ||
| Long-term loans and advances | ||
| Current investments | ||
| Inventories | ||
| Trade receivables | ||
| Cash and bank balances | ||
| Short-term loans and advances | ||
| Other current assets | ||
| Total assets | ||
Profit and loss statement of MAXIMORE PHARMA FUTURE LLP
In full report
Revenue, expenses and profit as filed in the annual financial statements, for up to the last 5 financial years.
| Particulars | FY 2025-26 | FY 2024-25 |
|---|---|---|
| Revenue from operations | ||
| Other income | ||
| Total income | ||
| Cost of materials consumed | ||
| Purchases of stock in trade | ||
| Employee benefit expenses | ||
| Finance costs | ||
| Depreciation and amortisation | ||
| Other expenses | ||
| Total expenses | ||
| Profit before tax | ||
| Current tax | ||
| Deferred tax | ||
| Profit after tax | ||
| Earnings per share (basic) | ||
| Earnings per share (diluted) |
Charges (secured loans) of MAXIMORE PHARMA FUTURE LLP
In full report
Loans secured against the company's assets and registered with the ROC: lender, amount and whether the charge is open or satisfied.
| Charge ID | Charge holder | Amount (₹) | Created on | Modified on | Satisfied on | Assets under charge | Status |
|---|---|---|---|---|---|---|---|
Auditors of MAXIMORE PHARMA FUTURE LLP
In full report
Statutory auditors appointed by the company over the years, as reported in its annual filings.
| Financial year | Auditor / firm | Firm registration no. | Signing partner | Membership no. | Appointed on |
|---|---|---|---|---|---|
Board meetings and resolutions of MAXIMORE PHARMA FUTURE LLP
In full report
Resolutions passed by the board or shareholders and filed with the Registrar of Companies (MGT-14).
| Date of filing | Date of resolution | Section | Subject of resolution | Resolution type | Agreed by |
|---|---|---|---|---|---|
Fund raising and allotments of MAXIMORE PHARMA FUTURE LLP
In full report
Shares or debentures allotted by the company (PAS-3), including any funding raised from investors.
| Date of allotment | Security type | Number of securities | Nominal value (₹) | Premium (₹) | Total amount (₹) | Allotted to |
|---|---|---|---|---|---|---|
Subsidiaries, associates and joint ventures of MAXIMORE PHARMA FUTURE LLP
In full report
Holding, subsidiary, associate and joint venture companies as per the latest annual return.
| CIN / identifier | Name | Relationship | Shares held (%) |
|---|---|---|---|
Outstanding payments to micro and small enterprises of MAXIMORE PHARMA FUTURE LLP
In full report
Half-yearly MSME-1 returns of payments the company has delayed beyond 45 days to micro and small suppliers.
| Return period | Filed on | Amount due (₹) | Days outstanding | Reason for delay |
|---|---|---|---|---|
Complaints of MAXIMORE PHARMA FUTURE LLP
In full report
Investor complaints and serious complaints recorded against the company or its directors with the Registrar.
| Date | Complaint type | Against | Particulars | Status |
|---|---|---|---|---|
Similar companies
Other companies in 500032
- QUALRUBRIKAI PRIVATE LIMITEDSeri Lingampally · 2026
- GANESH INFRAWORKS LLPSeri Lingampally · 2026
- IDWTEAM IT SERVICES PRIVATE LIMITEDSeri Lingampally · 2026
- SAINAM LLP2026
- ORO PROPTECH LLP2026
- LUMIOR COGNITIVE TECHNOLOGIES PRIVATE LIMITED2026
- DYNAMIC AERIAL VEHICLES PRIVATE LIMITED2026
- APEXPOWER EXCHANGE LIMITED2026
- FLYMENU AVIATION PRIVATE LIMITED2026
- INVITALY BUSINESS LOUNGE PRIVATE LIMITED2026
Update information
Last updated on: 08 Nov 2026, 12:28 PM
Is this information out of date, or does something not match? Tell us and we will check it against the latest MCA records.
Is this your llp?
Annual ROC filings, GST, TDS and bookkeeping, handled by one team with live reports in Genie.